In a shift away from next-generation Covid-19 vaccines, the Trump administration is investing $500 million in a vaccine ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

In the deadly summer of 2020, Hispanics in Texas were half of all COVID-19 deaths, spurring many to vaccinate. Today, in a ...

According to the WSJ, the universal vaccine project is being pioneered by two recently appointed senior scientists in the NIH ...

Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its ...

Receiving a COVID-19 booster vaccine in the same arm as the first vaccine dose leads to a faster, more effective immune ...

The potential change outlined in a statement would require all new vaccines to undergo placebo testing, sparking concerns ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

Pa. health experts say pandemic mistakes likely contributed to falling rates of vaccination against measles, other diseases.

Notes from a recent meeting of the CDC’s Advisory Committee on Immunization Practices’ COVID-19 Work Group show health ...

In addition, HHS Secretary Robert F. Kennedy Jr addressed the delay in Novavax's approval in a CBS interview earlier this ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.